208 related articles for article (PubMed ID: 29423813)
1. Exosomes in Pancreatic Cancer: from Early Detection to Treatment.
Armstrong EA; Beal EW; Chakedis J; Paredes AZ; Moris D; Pawlik TM; Schmidt CR; Dillhoff ME
J Gastrointest Surg; 2018 Apr; 22(4):737-750. PubMed ID: 29423813
[TBL] [Abstract][Full Text] [Related]
2. Exosomes as therapeutic solutions for pancreatic cancer.
Farran B; Nagaraju GP
Drug Discov Today; 2020 Dec; 25(12):2245-2256. PubMed ID: 33127355
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.
Qiu J; Yang G; Feng M; Zheng S; Cao Z; You L; Zheng L; Zhang T; Zhao Y
Mol Cancer; 2018 Jan; 17(1):2. PubMed ID: 29304816
[TBL] [Abstract][Full Text] [Related]
4. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer.
Jin H; Liu P; Wu Y; Meng X; Wu M; Han J; Tan X
Cancer Sci; 2018 Sep; 109(9):2946-2956. PubMed ID: 30007115
[TBL] [Abstract][Full Text] [Related]
5. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer.
Wu H; Chen X; Ji J; Zhou R; Liu J; Ni W; Qu L; Ni H; Ni R; Bao B; Xiao M
Genet Test Mol Biomarkers; 2019 Mar; 23(3):215-222. PubMed ID: 30793953
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.
Fan J; Wei Q; Koay EJ; Liu Y; Ning B; Bernard PW; Zhang N; Han H; Katz MH; Zhao Z; Hu Y
Theranostics; 2018; 8(21):5986-5994. PubMed ID: 30613276
[No Abstract] [Full Text] [Related]
7. Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2.
Cao W; Dai S; Ruan W; Long T; Zeng Z; Lei S
J Cell Mol Med; 2023 Sep; 27(17):2533-2546. PubMed ID: 37488774
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer.
Shang S; Wang J; Chen S; Tian R; Zeng H; Wang L; Xia M; Zhu H; Zuo C
Cancer Med; 2019 Dec; 8(18):7728-7740. PubMed ID: 31642612
[TBL] [Abstract][Full Text] [Related]
9. Exosomes as new therapeutic vectors for pancreatic cancer treatment.
Oliveira C; Calmeiro J; Carrascal MA; Falcão A; Gomes C; Miguel Neves B; Teresa Cruz M
Eur J Pharm Biopharm; 2021 Apr; 161():4-14. PubMed ID: 33561524
[TBL] [Abstract][Full Text] [Related]
10. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
Srinivas L; S D; Kgk D; Malla RR
Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
[TBL] [Abstract][Full Text] [Related]
11. Functions and clinical applications of exosomes in pancreatic cancer.
Jiang Z; Wang H; Mou Y; Li L; Jin W
Mol Biol Rep; 2022 Nov; 49(11):11037-11048. PubMed ID: 36097109
[TBL] [Abstract][Full Text] [Related]
12. Exosomes as Pleiotropic Players in Pancreatic Cancer.
De Lellis L; Florio R; Di Bella MC; Brocco D; Guidotti F; Tinari N; Grassadonia A; Lattanzio R; Cama A; Veschi S
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33803470
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer and associated exosomes.
Zhao C; Gao F; Weng S; Liu Q
Cancer Biomark; 2017 Dec; 20(4):357-367. PubMed ID: 29036786
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway.
Cao W; Zeng Z; He Z; Lei S
Aging (Albany NY); 2021 Feb; 13(5):7120-7132. PubMed ID: 33653966
[TBL] [Abstract][Full Text] [Related]
15. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
Xu B; Chen Y; Peng M; Zheng JH; Zuo C
Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1.
Li M; Zhou J; Zhang Z; Li J; Wang F; Ma L; Tian X; Mao Z; Yang Y
Chin Med J (Engl); 2022 Oct; 135(19):2326-2337. PubMed ID: 36535010
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro P; Macedo G; Melo SA
Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
[TBL] [Abstract][Full Text] [Related]
18. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis.
Yao X; Mao Y; Wu D; Zhu Y; Lu J; Huang Y; Guo Y; Wang Z; Zhu S; Li X; Lu Y
Cancer Lett; 2021 Aug; 512():38-50. PubMed ID: 33971282
[TBL] [Abstract][Full Text] [Related]
19. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review.
Sha G; Zhang W; Jiang Z; Zhao Q; Wang D; Tang D
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130149. PubMed ID: 38365161
[TBL] [Abstract][Full Text] [Related]
20. Exosomes and their roles in the chemoresistance of pancreatic cancer.
Pan Y; Tang H; Li Q; Chen G; Li D
Cancer Med; 2022 Dec; 11(24):4979-4988. PubMed ID: 35587712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
